These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 7627336

  • 1. Technetium-99m pentavalent dimercaptosuccinic acid imaging in patients with pituitary adenomas.
    Lastoria S, Colao A, Vergara E, Ferone D, Varrella P, Merola B, Lombardi G, Salvatore M.
    Eur J Endocrinol; 1995 Jul; 133(1):38-47. PubMed ID: 7627336
    [Abstract] [Full Text] [Related]

  • 2. (99m)Technetium pentavalent dimercaptosuccinic acid scintigraphy in the follow-up of clinically nonfunctioning pituitary adenomas after radiotherapy.
    Colao A, Ferone D, Lombardi G, Lastoria S.
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):713-21. PubMed ID: 12072040
    [Abstract] [Full Text] [Related]

  • 3. Differentiation of pituitary adenomas from other sellar and parasellar tumors by 99mTc(V)-DMSA scintigraphy.
    Yamamura K, Suzuki S, Yamamoto I.
    Neurol Med Chir (Tokyo); 2003 Apr; 43(4):181-6; discussion 187. PubMed ID: 12760496
    [Abstract] [Full Text] [Related]

  • 4. Impaired growth hormone secretion in patients operated for pituitary adenomas.
    Hoeck HC, Bang F, Laurberg P.
    Growth Regul; 1994 Jun; 4(2):63-7. PubMed ID: 7950904
    [Abstract] [Full Text] [Related]

  • 5. Clinical usefulness of 99mTc-HYNIC-TOC, 99mTc(V)-DMSA, and 99mTc-MIBI SPECT in the evaluation of pituitary adenomas.
    Vukomanovic VR, Matovic M, Doknic M, Ignjatovic V, Simic Vukomanovic I, Djukic S, Peulic M, Djukic A.
    Nucl Med Commun; 2019 Jan; 40(1):41-51. PubMed ID: 30334858
    [Abstract] [Full Text] [Related]

  • 6. Results of somatostatin receptor scintigraphy do not predict pituitary tumor volume- and hormone-response to ocreotide therapy and do not correlate with tumor histology.
    Plöckinger U, Bäder M, Hopfenmüller W, Saeger W, Quabbe HJ.
    Eur J Endocrinol; 1997 Apr; 136(4):369-76. PubMed ID: 9150695
    [Abstract] [Full Text] [Related]

  • 7. Diagnosis and treatment of pituitary adenomas.
    Chanson P, Salenave S.
    Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
    [Abstract] [Full Text] [Related]

  • 8. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
    Plöckinger U, Reichel M, Fett U, Saeger W, Quabbe HJ.
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
    [Abstract] [Full Text] [Related]

  • 9. Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide.
    Colao A, Ferone D, Lastoria S, Cerbone G, Di Sarno A, Di Somma C, Lucci R, Lombardi G.
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):437-45. PubMed ID: 10762286
    [Abstract] [Full Text] [Related]

  • 10. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
    Gsponer J, De Tribolet N, Déruaz JP, Janzer R, Uské A, Mirimanoff RO, Reymond MJ, Rey F, Temler E, Gaillard RC, Gomez F.
    Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
    [Abstract] [Full Text] [Related]

  • 11. Technetium-99m-pentavalent dimercaptosuccinic acid uptake in Hurthle cell tumor of the thyroid.
    Vergara E, Lastoria S, Varrella P, Lapenta L, Salvatore M.
    J Nucl Biol Med (1991); 1993 Jun; 37(2):65-8. PubMed ID: 8396979
    [Abstract] [Full Text] [Related]

  • 12. Follicle-stimulating hormone-secreting pituitary adenomas.
    Beckers A, Stevenaert A, Mashiter K, Hennen G.
    J Clin Endocrinol Metab; 1985 Sep; 61(3):525-8. PubMed ID: 2991325
    [Abstract] [Full Text] [Related]

  • 13. Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas.
    Arafah BM.
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1173-9. PubMed ID: 3009521
    [Abstract] [Full Text] [Related]

  • 14. Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas.
    Ferone D, Lastoria S, Colao A, Varrella P, Cerbone G, Acampa W, Merola B, Salvatore M, Lombardi G.
    J Clin Endocrinol Metab; 1998 Jan; 83(1):248-52. PubMed ID: 9435450
    [Abstract] [Full Text] [Related]

  • 15. Clinical Characteristics and Management of Cosecreting Thyroid Stimulating Hormone or Prolactin Pituitary Growth Hormone Adenomas: A Case-Control Study.
    Mo C, Chen H, Xu J, Guo Y, Wang Y, Li Z, Tong T, Gui S, Zhong L.
    Endocr Pract; 2024 May; 30(5):441-449. PubMed ID: 38307455
    [Abstract] [Full Text] [Related]

  • 16. Relationship between plasma prolactin concentration and pituitary function in patients with a pituitary adenoma.
    Hagen C, Lindholm J, Suenson E, Riishede J, Hummer L, Jacobsen HH.
    Clin Endocrinol (Oxf); 1979 Dec; 11(6):671-9. PubMed ID: 231491
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N.
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [Abstract] [Full Text] [Related]

  • 18. The pituitary uptake of (111)In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomas.
    Colao A, Lastoria S, Ferone D, Varrella P, Marzullo P, Pivonello R, Cerbone G, Acampa W, Salvatore M, Lombardi G.
    J Endocrinol Invest; 1999 Mar; 22(3):176-83. PubMed ID: 10219884
    [Abstract] [Full Text] [Related]

  • 19. In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand.
    de Herder WW, Reijs AE, Kwekkeboom DJ, Hofland LJ, Nobels FR, Oei HY, Krenning EP, Lamberts SW.
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):755-67. PubMed ID: 9039343
    [Abstract] [Full Text] [Related]

  • 20. Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid.
    Ugur O, Kostakğlu L, Güler N, Caner B, Uysal U, Elahi N, Haliloğlu M, Yüksel D, Aras T, Bayhan H, Bekdik C.
    Eur J Nucl Med; 1996 Oct; 23(10):1367-71. PubMed ID: 8781142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.